首页> 美国卫生研究院文献>other >Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study

【2h】

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study

机译：晚期卵巢癌的手术和腹膜内化疗之间的时间间隔对预后有影响吗？ NRG肿瘤/妇科肿瘤小组研究辅助研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesTo determine the relationship of the time from surgery to intraperitoneal (IP) chemotherapy (TSIC) initiation with survival of patients with stage III epithelial ovarian cancer (EOC) patients using ancillary data from cooperative group clinical trials.

机译：目的使用合作组临床试验的辅助数据确定手术开始至腹膜内（IP）化疗（TSIC）的时间与III期上皮性卵巢癌（EOC）患者生存的关系。

著录项

期刊名称 other
作者
Arlene E Garcia-Soto; James J Java; Wilberto Nieves Neira; J Matthew Pearson; David E. Cohn; Shashikant B Lele; Krishnansu S Tewari; Joan L Walker; Angeles Alvarez Secord; Deborah K Armstrong; Larry J Copeland;
展开▼
作者单位

展开▼
年(卷),期 -1(143),3
年度 -1
页码 484–489
总页数 16
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study [J] . Garcia-Soto Arlene E., Java James J., Neira Wilberto Nieves, Gynecologic Oncology: An International Journal . 2016 ,第3期

机译：晚期卵巢癌手术与腹膜内化疗之间的时间间隔是否会对预后产生影响？ NRG肿瘤/妇科肿瘤小组研究辅助研究
2. Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study [J] . Garcia-Soto Arlene E., Java James J., Neira Wilberto Nieves, Gynecologic Oncology: An International Journal . 2016 ,第3期

机译：手术和腹膜内化疗之间的时间间隔在晚期卵巢癌中携带预后的影响吗？ NRG肿瘤学/妇科肿瘤学群体研究辅助研究
3. Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study [J] . Walker Joan L., Brady Mark F., Wenzel Lari, Journal of Clinical Oncology . 2019 ,第16期

机译：静脉内与腹膜内化疗的随机试验加上晚期卵巢癌中的Bevacizumab：NRG肿瘤学/妇科肿瘤学群体研究
4. Sodium selenite in gynecologic radiation oncology. Results of a phase III study [C] . Muecke, R., Glatzel, Workshop on Macro, Trace and Ultratrace Elements; 20040924-25; Jena(DE) . 2004

机译：亚硒酸钠在妇科放射肿瘤学中的应用。第三阶段研究的结果
5. Comfort Levels of Gynecology Cancer Patients Receiving Intraperitoneal Chemotherapy: A Pilot Study. [D] . Whyte, Darlene. 2010

机译：接受腹腔化疗的妇科癌症患者的舒适度水平：一项先导研究。
6. Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study [O] . Joan L. Walker, Mark F. Brady, Lari Wenzel, -1

机译：晚期卵巢癌静脉和腹腔内化疗联合贝伐单抗随机对照试验：NRG肿瘤/妇科肿瘤小组研究
7. Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study [O] . Arlene E Garcia-Soto, James J Java, Wilberto Nieves Neira, 2016

机译：手术和腹膜内化疗之间的时间间隔在晚期卵巢癌中携带预后的影响吗？ NRG肿瘤学/妇科肿瘤学群体研究辅助研究

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study

摘要

著录项

相似文献

相关主题

期刊订阅